期刊文献+

两种挑除闭合性粉刺的方法和效果观察

Two kinds of methods and effects of removing closed acne
下载PDF
导出
摘要 目的:探讨有效挑除闭合性粉刺的方法。方法:收治闭合性粉刺患者240例,随机分为对照组和观察组各120例。对照组采用传统方法挑除,观察组采用改良方法挑除。结果:观察组患者疼痛0级比例和1级比例均高于对照组,2级比例低于对照组,疼痛程度轻于对照组(P<0.05);观察组患者一次挤压成功率显著高于对照组(P<0.05)。结论:对闭合性粉刺患者采用改良挑除法能够减轻患者的疼痛,且操作简单,引起的不良反应较小。 Objective:To investigate the effective method of removing closed acne.Methods:240patients with closed acne wereselected.They were randomly divided into the control group and the observation group with120cases in each group.The controlgroup was selected by traditional methods,and the observation group was selected by the improved method.Results:The proportionof0grade and1grade of the observation group were higher than that of the control group,and the proportion of the2grade waslower than that of the control group,the degree of pain was less than that of the control group(P<0.05).The success rate of theone-time crush of the observation group was significantly higher than that of the control group(P<0.05).Conclusion:For patientswith closed acne,the modified acupuncture can reduce the pain of the patient,and the operation is simple,resulting in less adversereactions.
作者 关欣 Guan Xin(Department of Skin,the People's Hospital of Wufeng County,Hubei Province 443400)
出处 《中国社区医师》 2017年第24期36-36,38,共2页 Chinese Community Doctors
关键词 闭合性粉刺 挑除方法 应用效果 Closed acne Selection method Application effect
  • 相关文献

参考文献5

二级参考文献47

  • 1孟琳,白云平,葛双启.果酸在化妆品中的应用[J].化学与生物工程,2005,22(4):45-46. 被引量:22
  • 2Thiboutot DM. Acne. An overview of clinical research findings [J]. Dermatol Clin, 1997, 15(1): 97-109.
  • 3Fuhrmann U, Krattenmacher R, Slater EP, et al. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential [ J ]. Contraception, 1996, 54(4): 243-251.
  • 4Krattenmacher R. Drospirenone: pharmacology and pharmaco- kinetics of a unique progestogen [J]. Contraception, 2000, 62 ( 1 ): 29-38.
  • 5Oelkers W, Berger V, Bolik A, et al. Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women [J]. J Clin Endocrinol Metab, 1991, 73(4): 837-842.
  • 6Muhn P, Fuhrmann U, Fritzemeier KH, et al. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenie activity[J]. Ann N Y Acad Sci, 1995, 761: 311-335.
  • 7Bachmann G, Sulak PJ, Sampson-Landers C, et al. Efficacy and safety of a low-dose 24-day combined oral contraceptivecontaining 20 micrograms ethinylestradiol anti 3 mg drospirenon I J ]. Contraception, 2004, 70( 3 ): 191-198.
  • 8Klipping C, Marr J. Effects of two combined oral contraceptives containing ethinyl cstradiol 20 microg combined with either drospirennne or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism[ J ]. Contraception, 2005, 71 (6): 409-416.
  • 9Dinger JC, Heinemann 1,A, Ktihl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the Eurupcan Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation[ J ]. Cuntraception, 2007, 75(5 ): 344-354.
  • 10Sceger .1D, Loughlin J, Eng PM, et al. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oralcontraceptives[ J ]. Obstet Gynecol, 2007, 110( 3 ): 587-593.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部